학술논문

Simeprevir, daclatasvir, and sofosbuvir for hepatitis C virus-infected patients: Long-term follow-up results from the open-label, Phase II IMPACT study
Document Type
Article
Source
In: Health Science Reports. (Health Science Reports, 1 June 2020, 3(2))
Subject
Language
English
ISSN
23988835